Clinical trial

Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in…

NCT00451256 · Sarepta Therapeutics, Inc., Industry · Terminated

Key facts

NCT number NCT00451256
Title Safety and Efficacy Study of AVI-5126 When Used on Vein Grafts Before Use in Heart by-Pass Graft Surgery (CABG)
Official title Clinical Study to Assess the Safety and Efficacy of ex-Vivo Vein Graft Exposure to AVI-5126 in Coronary Artery By-Pass Grafting to Reduce Clinical Graft Failure
Lead sponsor Sarepta Therapeutics, Inc., Industry
Status Terminated
Phase Phase 2
Study type Interventional
Conditions Cardiovascular Disease, Coronary Artery Bypass
Intervention type Drug
Interventions AVI-5126
Enrollment 600
Start date Mar 1, 2007
Primary completion Nov 1, 2007
Completion Mar 1, 2009
First posted Mar 23, 2007
Last update posted Jul 8, 2009
Countries Ukraine

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies